Olympia champion Ronnie Coleman along with his team owns and operates Ronnie Coleman Signature Series
This peptide-pathway genetic testing approach differs from standard pharmacogenomic screening and identifies whether you are a responder, slow responder, or candidate for dual-peptide therapy (combining semaglutide with tirzepatide)
It roams the cellular environment looking for unstable molecules and heavy metals, latching onto them so they can be safely escorted out of the body
Sander S, Coleman CI, Patel AA, Kluger J, White CM
Data are expressed as mean SEM
Research has demonstrated that the glutathione concentration in most cells is roughly equivalent to the amount of glucose and cholesterol, which is incredible